Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
about
TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cellsResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesEscaping Antiangiogenic Therapy: Strategies Employed by Cancer CellsPooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.E2F8 is a Potential Therapeutic Target for Hepatocellular CarcinomaRole of vascular permeability factor/vascular endothelial growth factor in eye disease.Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironmentVascular endothelial growth factor: environmental controls and effects in angiogenesis.Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect.Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model.Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.Inward transport of [3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: putative involvement of a P-glycoprotein transporterTranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo.Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina.
P2860
Q24300565-53F48E8C-8784-4D1D-853A-6B35E3980037Q27016629-5E59FED6-FCD0-4D3A-B401-553A4C374ADEQ28067753-CE52ACD9-31B1-4D16-9430-E068BE3252E9Q31018385-5E4312FE-1B50-4C1F-A4FA-15C4B517AEEDQ33776715-7E0BA543-6282-408A-B841-E8400F98424FQ35300661-C274F472-5EFE-4DB6-9B91-493A9B68527DQ35782383-41ADA47E-7DF9-4F3D-A0FF-1265AE29CAC7Q41078547-B68F001A-4C7E-456F-AE0E-AEC5B08F33FAQ41490097-6CE98983-0D8F-46A7-BE6A-DC068FA58103Q41854559-9CEDD67B-5E1E-4114-83E0-3CBD791B54AFQ41989268-EB45C3E1-7BE1-4C86-9563-7A166696ADBEQ42581775-E26DE3D8-E9E5-4806-9E52-9ADC4E7EDEFEQ43178739-27D1A0B5-C61A-47C3-85B6-46DE14696155Q46923873-C7A13A80-D5D8-41DA-8944-0B37DA225C4F
P2860
Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@ast
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@en
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@nl
type
label
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@ast
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@en
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@nl
prefLabel
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@ast
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@en
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@nl
P2860
P1476
Suppression of VEGF-induced an ...... nase inhibitor, lavendustin A.
@en
P2860
P304
P356
10.1111/J.1476-5381.1995.TB13221.X
P407
P577
1995-01-01T00:00:00Z